DFX Intelligence
Data Factory
Reading the graph
Reading the graph
healthcare
Data as of (this record's last observation) from Sworn filings; Announcements; Limited partners. Page built and rebuilt at most every 15 minutes.
| Announced | Type | Headline | EV | Basis |
|---|---|---|---|---|
| Mar 16, 2022 | Growth investment | Reaction Biology Announces Closing of Growth Investment from Cobepa and Chief Executive Officer Transition | n/a | n/a |
| Mar 15, 2022 | Exit strategic sale | Reaction Biology Acquired by Cobepa | n/a | n/a |
| Feb 19, 2019 | Add on acquisition | Reaction Biology Acquires ProQinase GmbH | n/a | n/a |
| Investor | Class | Role | Control | Invested | Status |
|---|---|---|---|---|---|
| Cobepa S.A | Hybrid manager | unknown | unknown | Mar 16, 2022 | active |
| 1315 Capital | Buyout | unknown | unknown | n/a | exited |
| BroadOak | n/a | platform | unknown | n/a | exited |
| Broadoak Asset Management, LLC | Buyout | platform | unknown | n/a | exited |
Also named here, with no published line of their own (reach them through the firm): Matt Oristano (CEO), John H. Johnson (CEO and Board Director).
Who to call is the organisation, the person's role and the line they published themselves: a business phone, office address, website or profile link from Form ADV, Form 13F or their own website, with that source named on every value. The counts above are what a reveal returns; a personal email is rarely published, so most reveals are the firm's line. Never data bought from a provider, never anything personal. Reveals by plan